PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Profound Medical Corp (PROF)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

CA74319B5027

CUSIP

74319B502

Sector

Healthcare

IPO Date

Jun 9, 2016

Highlights

Market Cap

$213.50M

EPS (TTM)

-$1.34

Total Revenue (TTM)

$6.98M

Gross Profit (TTM)

$4.51M

EBITDA (TTM)

-$23.92M

Year Range

$5.63 - $11.42

Target Price

$15.30

Short %

2.71%

Short Ratio

4.34

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Profound Medical Corp, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-40.00%-30.00%-20.00%-10.00%0.00%10.00%SeptemberOctoberNovemberDecember2025February
-23.96%
10.30%
PROF (Profound Medical Corp)
Benchmark (^GSPC)

Returns By Period

Profound Medical Corp had a return of -5.73% year-to-date (YTD) and -14.39% in the last 12 months.


PROF

YTD

-5.73%

1M

-3.67%

6M

-25.47%

1Y

-14.39%

5Y*

-15.90%

10Y*

N/A

^GSPC (Benchmark)

YTD

4.46%

1M

2.46%

6M

9.31%

1Y

23.49%

5Y*

13.03%

10Y*

11.31%

*Annualized

Monthly Returns

The table below presents the monthly returns of PROF, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025-14.11%-5.73%
20245.01%3.20%-7.28%-12.78%-0.94%13.84%26.10%-13.52%-13.01%-8.67%11.69%-7.51%-11.54%
202313.41%6.48%-29.35%24.87%3.88%7.97%-11.99%-22.36%14.74%-18.53%30.57%-21.75%-22.04%
2022-11.84%7.98%-15.81%-18.89%26.99%-21.36%18.11%-19.28%-41.87%2.48%14.98%128.78%-3.03%
202127.04%-15.66%-8.58%-9.88%-2.64%-7.41%-10.76%1.78%-1.48%-7.72%-18.95%2.56%-45.38%
202052.42%-21.81%-25.36%38.30%-8.39%37.28%-6.85%-6.84%20.00%-4.25%18.06%3.11%87.76%
201950.00%-2.17%-2.32%16.41%-12.23%-2.46%3.15%22.60%8.17%16.72%-18.06%39.49%160.71%
201827.34%-0.72%-9.08%-0.81%11.56%-9.64%1.47%-9.83%-20.85%-17.64%1.81%-7.77%-35.64%
2017-1.60%-5.96%-1.94%7.29%-13.35%2.95%15.66%-0.50%-1.95%-14.58%-21.07%24.14%-17.98%
2016-2.80%11.62%-13.95%-16.39%-3.55%3.77%-21.88%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of PROF is 30, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of PROF is 3030
Overall Rank
The Sharpe Ratio Rank of PROF is 2929
Sharpe Ratio Rank
The Sortino Ratio Rank of PROF is 2929
Sortino Ratio Rank
The Omega Ratio Rank of PROF is 2929
Omega Ratio Rank
The Calmar Ratio Rank of PROF is 3333
Calmar Ratio Rank
The Martin Ratio Rank of PROF is 3232
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Profound Medical Corp (PROF) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for PROF, currently valued at -0.32, compared to the broader market-2.000.002.00-0.321.74
The chart of Sortino ratio for PROF, currently valued at -0.14, compared to the broader market-4.00-2.000.002.004.006.00-0.142.35
The chart of Omega ratio for PROF, currently valued at 0.98, compared to the broader market0.501.001.502.000.981.32
The chart of Calmar ratio for PROF, currently valued at -0.21, compared to the broader market0.002.004.006.00-0.212.61
The chart of Martin ratio for PROF, currently valued at -0.68, compared to the broader market0.0010.0020.0030.00-0.6810.66
PROF
^GSPC

The current Profound Medical Corp Sharpe ratio is -0.32. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Profound Medical Corp with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00SeptemberOctoberNovemberDecember2025February
-0.32
1.74
PROF (Profound Medical Corp)
Benchmark (^GSPC)

Dividends

Dividend History


Profound Medical Corp doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-74.80%
0
PROF (Profound Medical Corp)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Profound Medical Corp. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Profound Medical Corp was 99.74%, occurring on Jul 19, 2017. Recovery took 375 trading sessions.

The current Profound Medical Corp drawdown is 74.80%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.74%Aug 22, 201680Jul 19, 2017375Sep 9, 2019455
-88.68%Feb 8, 2021434Oct 26, 2022
-65.1%Feb 10, 202030Mar 23, 2020175Nov 30, 2020205
-45.76%Sep 10, 201924Oct 11, 201952Dec 26, 201976
-17.15%Dec 27, 20199Jan 9, 20202Jan 13, 202011

Volatility

Volatility Chart

The current Profound Medical Corp volatility is 13.61%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%SeptemberOctoberNovemberDecember2025February
13.61%
3.07%
PROF (Profound Medical Corp)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Profound Medical Corp over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Profound Medical Corp.


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab